title: Community-based harm reduction substance abuse treatment with methamphetamine-using men who have sex with men.
abstract: Harm reduction approaches endeavor to assist individuals with avoiding the most detrimental consequences of risk taking behaviors, but limited research has documented the outcomes of harm reduction substance abuse treatment. In total, 211 methamphetamine-using men who have sex with men (MSM) enrolled in two outcome studies of substance abuse treatment programs that were implementing an evidence-based, cognitive-behavioral intervention (i.e., the Matrix Model) from a harm reduction perspective. Study 1 (N = 123) examined changes in self-reported substance use, Addiction Severity Index (ASI) composite scores, and HIV care indicators over a 12-month follow-up. Study 2 (N = 88) assessed changes in substance use, sexual risk taking, and HIV care indicators over a 6-month follow-up. Participants in study 1 reported reductions in cocaine/crack use as well as decreases in the ASI drug and employment composite scores. Among HIV-positive participants in study 1 (n = 75), 47 % initiated or consistently utilized anti-retroviral therapy and this was paralleled by significant increases in self-reported undetectable HIV viral load. Study 2 participants reported reductions in methamphetamine use, erectile dysfunction medication use in combination with other substances, and sexual risk-taking behavior while using methamphetamine. Participants in both studies reported concurrent increases in marijuana use. Taken together, these studies are among the first to observe that clients may reduce stimulant use and concomitant sexual risk-taking behavior during harm reduction substance abuse treatment. Randomized controlled trials are needed to examine the differential effectiveness of harm reduction and abstinence-based approaches to substance abuse treatment.
authors.affiliation: University of California, San Francisco School of Nursing, 2 Koret Way, N511M, San Francisco, CA, 94143, USA, adam.carrico@ucsf.edu.
authors.forename: Adam W
authors.initials: AW
authors.lastname: Carrico
authors.forename: Annesa
authors.initials: A
authors.lastname: Flentje
authors.forename: Valerie A
authors.initials: VA
authors.lastname: Gruber
authors.forename: William J
authors.initials: WJ
authors.lastname: Woods
authors.forename: Michael V
authors.initials: MV
authors.lastname: Discepola
authors.forename: Samantha E
authors.initials: SE
authors.lastname: Dilworth
authors.forename: Torsten B
authors.initials: TB
authors.lastname: Neilands
authors.forename: Jennifer
authors.initials: J
authors.lastname: Jain
authors.forename: Michael D
authors.initials: MD
authors.lastname: Siever
mesh_terms: D000328:Adult; D019969:Amphetamine-Related Disorders / Q000517:prevention & control*; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control; D018451:Homosexuality, Male / Q000523:psychology / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008694:Methamphetamine; D016320:Substance Abuse Treatment Centers / Q000379:methods; D019966:Substance-Related Disorders / Q000517:prevention & control*; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D008694:Methamphetamine
references.citation: J Infect Dis. 2003 Dec 15;188(12):1820-6
references.pmid: 14673760
references.citation: AIDS Educ Prev. 2003 Apr;15(2):133-47
references.pmid: 12739790
references.citation: J Consult Clin Psychol. 2008 Oct;76(5):829-39
references.pmid: 18837600
references.citation: Int J STD AIDS. 2000 Sep;11(9):579-85
references.pmid: 10997499
references.citation: J Acquir Immune Defic Syndr. 2007 May 1;45(1):85-92
references.pmid: 17325605
references.citation: Clin Infect Dis. 2012 Dec;55(12):1690-7
references.pmid: 22955429
references.citation: AIDS Behav. 2012 Jan;16(1):121-31
references.pmid: 21644001
references.citation: N Engl J Med. 2011 Aug 11;365(6):493-505
references.pmid: 21767103
references.citation: J Psychoactive Drugs. 2001 Jan-Mar;33(1):23-6
references.pmid: 11332997
references.citation: AIDS. 2007 Jan 11;21(2):239-41
references.pmid: 17197817
references.citation: Drug Alcohol Depend. 2007 Mar 16;87(2-3):249-57
references.pmid: 17182196
references.citation: Drug Alcohol Depend. 2013 Oct 1;132(3):624-9
references.pmid: 23684632
references.citation: Biometrics. 2002 Mar;58(1):1-12
references.pmid: 11890304
references.citation: Addiction. 2007 May;102(5):684-90
references.pmid: 17506148
references.citation: AIDS Behav. 2007 Sep;11(5 Suppl):S6-16
references.pmid: 17577655
references.citation: Am J Epidemiol. 2001 Dec 15;154(12 Suppl):S70-7
references.pmid: 11744532
references.citation: J Subst Abuse Treat. 2008 Oct;35(3):285-93
references.pmid: 18329226
references.citation: Drug Alcohol Depend. 2000 Apr 1;59(1):17-31
references.pmid: 10706972
references.citation: Sex Transm Infect. 2008 Nov;84(6):458-62
references.pmid: 19028947
references.citation: Lancet. 1999 May 15;353(9165):1657-61
references.pmid: 10335785
references.citation: Lancet. 2010 Aug 7;376(9739):458-74
references.pmid: 20650520
references.citation: AIDS. 2008 Jul 11;22(11):1355-63
references.pmid: 18580615
references.citation: AIDS. 2006 Mar 21;20(5):731-9
references.pmid: 16514304
references.citation: J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S174-8
references.pmid: 23764632
references.citation: Addiction. 2006 Nov;101(11):1546-60
references.pmid: 17034434
references.citation: Am Clin Lab. 2002 May;21(4):16-8
references.pmid: 12087633
references.citation: J Subst Abuse Treat. 2006 Apr;30(3):237-43
references.pmid: 16616168
references.citation: J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):639-43
references.pmid: 18285715
references.citation: J Addict Dis. 1998;17(4):19-32
references.pmid: 9848029
references.citation: Drug Alcohol Depend. 2005 May 9;78(2):125-34
references.pmid: 15845315
references.citation: J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):146-50
references.pmid: 21116186
references.citation: J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):349-55
references.pmid: 19387357
references.citation: Life Sci. 2011 May 23;88(21-22):940-7
references.pmid: 20934437
references.citation: J Subst Abuse Treat. 1992;9(3):199-213
references.pmid: 1334156